Cheng, Pin-Nan <br/><br/>
Entecavir: a potent antiviral with minimal long-term resistance in nucleoside-naive chronic hepatitis B patients.  [electronic resource] 

 -  Expert review of anti-infective therapy  Oct 2008 
 - 569-79 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-8336 
<br/><br/><label>Standard No.: </label>10.1586/14787210.6.5.569  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antiviral Agents--administration & dosage<br/>Clinical Trials, Phase III as Topic<br/>DNA, Viral--blood<br/>Drug Resistance, Viral<br/>Guanine--administration & dosage<br/>Hepatitis B e Antigens--blood<br/>Hepatitis B virus--drug effects<br/>Hepatitis B, Chronic--drug therapy<br/>Humans<br/>Randomized Controlled Trials as Topic<br/>Time Factors<br/>Treatment Outcome